Ipamorelin

Ipamorelin is a laboratory-designed peptide investigated for its ability to promote growth hormone secretion. Proposed effects on body composition, recovery, skin properties, and sleep should not be interpreted as established clinical benefits.

Ghrelin participates in the regulation of appetite and growth hormone secretion. Growth hormone is normally released in intermittent bursts, but stimulating its secretion does not necessarily normalize those patterns or produce beneficial health outcomes.

Ipamorelin has been investigated as a ghrelin-mimetic compound that promotes growth hormone release. The guide characterizes this activity as relatively selective, with comparatively little influence on cortisol, prolactin, or appetite, but provides no supporting study details. Its suggestion that the compound normalizes hormonal pulses requires separate evidence beyond increased secretion.

1. 01

   Molecular target

2. 02

   Cellular signal

3. 03

   Biological process

LEVEL 02 · Preclinical research

Laboratory or animal research exists. Findings do not transfer reliably to people.

Evidence levels reflect the state of documented research only. They are not rankings of popularity, quality or suitability, and a higher level never implies that a compound is an approved medicine.

The source guide presents ipamorelin as a selective stimulator of growth hormone secretion and attributes a favorable tolerability profile to it. It associates the compound with muscle development, lipid metabolism, tissue recovery, collagen-related skin changes, and improved sleep. These statements are claims from a non-peer-reviewed guide rather than a documented assessment of clinical evidence.

Source: The Complete Guide to Peptides: Unlocking the Secrets to Health, Healing and Longevity — Hack Smith, Chapter 6, Introduction to Peptides (page references not verified)

Summarised in our own wording from the cited reference. The reference is a popular guide, not peer-reviewed literature; its statements are reported here as source claims rather than established facts.

Dosage, reconstitution and administration guidance is deliberately excluded from this platform.

The supplied material does not establish whether the proposed benefits occur in humans or are clinically meaningful. Comparative selectivity, normalization of secretion patterns, and longer-term safety remain insufficiently substantiated by these notes.

Safety data are limited, and the guide's strong comparative safety claims cannot be verified from the supplied information. The guide mentions headaches and localized redness or irritation, but does not provide reliable frequencies or a comprehensive risk assessment. This summary is educational and is not medical advice.

Research-stage compound unless otherwise established by a competent authority. Regulatory classification differs between jurisdictions and can change over time; nothing here indicates marketing authorisation.

Primary reference for this entry:

The Complete Guide to Peptides: Unlocking the Secrets to Health, Healing and Longevity — Hack Smith, Chapter 6, Introduction to Peptides (page references not verified)

Suggested literature search terms taken from the source. They are search starting points, not citations to specific studies.

• “lpamorelin growth hormone secretion”
• “lpamorelin for fat loss and muscle growth”
• “Ipamorelin peptide clinical trial”

Editorial status

source reviewed

Last updated

2026-09-14

Last reviewed

2026-09-13

Language

EN